Investors

Announcements

Interim Results for the six months ended 30 September 2020

31 December 2020

CHIEF EXECUTIVE'S REPORT

 
Download
These results are available to
view and download in PDF format

I am pleased to report the interim accounts to 30 September 2020 for TruSpine Technologies plc.  It should be noted that, although these accounts represent a six-month period, the 6-month period to 30 September 2020 ended approximately five weeks after the Company's IPO on the Aquis Stock Exchange Growth Market. Therefore, there is little to report for the period that was not already included in detail in the Company's Admission Document.

The Company is still in its pre-revenue development phase and remains loss-making.  The loss before taxation for the six months to 30 September 2020 was £448k (2019: £122k) after administrative expenses of £443k (2019: £120k).  Development spend for the six months to 30 September 2020 was £277k (2019: £54k).

Consolidated net assets as at 30 September 2020 amounted to £2.425 million (2019: £1.165 million) including cash and cash equivalents of £567,000 (2019: £47,000).

The IPO has provided the Company with a stronger corporate platform upon which to build its future, and also attracted attention from supporters and potential trade partners, the Company's technology continues to generate positive feedback and excitement from medical professionals within the spine industry.  The Board therefore looks to the future with confidence, and believe that 2021 will see patients directly benefiting from the Company's technology.

On behalf of the Board, I would once again like to thank shareholders for their support, and TruSpine's staff and commercial partners for their continued dedication and hard work, during what has undoubtedly been a challenging time for us all.

Ian Roberts

Chief Executive

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").

The Directors of the Company take responsibility for this announcement.

 

Enquiries:

TruSpine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 
  

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 
  

WH Ireland (Broker)

Tel: +44 (0)20 7220 1666

Adam Pollock

 
  

Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

GROUP UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2020

GROUP STATEMENT OF COMPREHENSIVE INCOME

  6 month
period ended
30 September 2020
(Unaudited)
6 month
period ended
30 September 2019
(Audited)
Year
ended
29 March 2020
(Audited)
     
 Note   
  ££ £
     
Administrative expenses  (443,458)(120,187) (340,373)
     
Operating loss  (443,458)(120,187) (340,373)
Finance expense     (4,516)(1,995)    (3,224)
     
Loss before tax (447,974)(122,182)(343,957)
     
     
Tax credit       24,826162,191 162,191
     
(Loss)/Profit (423,148)40,009(181,766)
     
Loss attributable to:     
     
Owners of the parent  (423,148)40,009   (181,766)
     
Other comprehensive income:    
Items that will or may be reclassified to profit or loss:     
Exchange translation differences on foreign operations     1,762   (8,668)    (2,565)
Total comprehensive loss  (421,299)   (31,341)    (2,565)
     
     
Total comprehensive loss attributable to equity shareholders  (421,299)   (31,341)    (184,331)
     
     
Earnings per share basic and diluted (pence) 5 (0.50)p0.05p (0.24)p

All results in the current and preceding financial period derive from continuing operations.

 

GROUP STATEMENT OF FINANCIAL POSITION

  30 September 2020
(Unaudited)
30 September 2019
(Audited)
29 March 2020
(Audited)
 Note££ £
     
Non-current assets    
Tangible fixed assets      21,154- -
Intangible assets  1,891,8011,443,298 1,614,696 
  1,912,9551,443,298 1,614,696 
     
Current assets    
Trade and other receivables  444,080104,524 160,889
Cash and cash equivalents  566,64847,439       135,035
     1,010,728151,963    295,924
     
Total assets    2,923,683   1,595,261    1,910,620
     
     
Current liabilities    
Trade and other payables  448,915430,105 216,925
Borrowings     50,000-    -
  498,915430,105 216,925
     
Total liabilities 498,915  430,105 216,925
     
Net Assets     2,424,7681,165,156 1,693,695
     
Equity attributable to owners of the parent     
Share capital 6 8,7787,607 8,385
Share premium  2,632,0982,978,602 3,727,035
Other reserves 6 (205,000)(200,000) (205,000)
Translation reserve  (19,844)(24,712) (18,609)
Retained earnings  8,736(1,596,341) (1,818,116)
     
Total equity attributable to owners of the parent  2,424,7681,165,156 1,693,695
     
Total Equity 2,424,768  1,165,156    1,693,695

 

GROUP STATEMENT OF CHANGES IN EQUITY

 Share capitalShare premiumOther reservesTranslation reserveRetained earningsTotal
 ££££££
       
Balance as at 29 March 20197,5802,920,599(200,000)(16,044)(1,636,350)(1,075,785)
Profit for the six months - ---40,00940,009
Other comprehensive loss - --(8,668)- (8,668)
Total comprehensive loss for the period- --(8,668)40,00931,341
Issue of shares, net of issue costs 27 58,003---58,030
Transactions with owners, recognised directly in equity27 58,003---58,030
Balance as at 30 September 20197,607 2,978,602(200,000)(24,712)(1,596,341)1,165,156
 
      
Balance as at 29 March 20208,3853,727,035(205,000)(18,609)(1,818,116)1,693,695
Loss for the six months - ---(423,148)(423,148)
Other comprehensive loss - --(1,235)- (1,235)
Total comprehensive loss for the period- --(1,235)(423,148)(424,383)
Issue of shares, net of issue costs 3931,155,063---1,155,456
Reduction in share capital (2,250,000) 2,250,000
Transactions with owners, recognised directly in equity393 (1,094,937) --2,250,0001,155,456
Balance as at 30 September 20208,778 2,632,098(205,000)(19,844)8,7362,424,768
       

 

CONSOLIDATED STATEMENT OF CASH FLOWS

  6 month
period ended
30 September 2020
(Unaudited)
6 month
period ended
30 September 2019
(Audited)
Year
ended
29 March 2020
(Audited)
     
  ££ £
     
Cash flow from operating activities    
     
Loss before tax  (447,974)(122,182) (343,957)
Depreciation and amortisation  -- -
(Increase)/decrease in other receivables  (283,191)51,676 (4,689)
Increase/(decrease) in other payables  231,990(39,674) (252,854)
Cash used in operations (499,175)(110,180) (601,500)
Income tax credit       24,826162,191 162,191
Net cash flows from operating activities (474,349)52,011     (439,309)
     
     
Investing activities    
     
Purchase of tangible assets  (21,154)- -
Purchase of intangible assets  (277,105)(54,041) (225,439)
Net cash used in investing activities       (298,259)(54,041) (225,439)
     
     
Financing activities    
Proceeds from Issue of shares, net of issue costs  1,155,45658,030 807,241
Acquisition of owner shares  -- (5,000)
Increase in borrowings  50,000- -
Net cash flow from financing 1,205,45658,030 802,241
     
Increase/(Decrease) in cash and cash equivalents in the period  432,84856,000 137,493
     
Cash and cash equivalents at the beginning of the year 135,035107 107
Exchange rate differences on cash and cash equivalents (1,235)(8,668) (2,565)
     
Cash and cash equivalents at the end of the period 566,64847,439 135,035